abstract |
The present invention relates to a composition for the treatment of aggressive cancer forms, including aggressive breast cancer, aggressive lung cancer, aggressive prostate cancer and aggressive pancreatic cancer, as well as metastatic cancer, comprising an antibody that specifically binds to an integrin alpha10 polypeptide or fragment thereof . The present invention also relates to a method for diagnosing and treating said aggressive cancer form. The present invention also relates to a method of predicting the survival rate of a subject affected by said aggressive cancer form. |